Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2020-11-04Clinical Trial Update: Efficacy and Safety of the Mometasone Nasal Gel in the Treatment of Persistent Allergic Rhinitis [Phase 3]
A Phase 3 trial evaluating mometasone nasal gel for persistent allergic rhinitis was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2020-11-04Clinical Trial Update: Efficacy and Safety of the Mometasone Nasal Gel in the Treatment of Persistent Allergic Rhinitis [Phase 3]
A Phase 3 trial evaluating mometasone nasal gel for persistent allergic rhinitis was withdrawn.
-
FDA approval · 2020-11-02FDA Approved: CHILDRENS ALLEGRA ALLERGY — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for Children's Allegra Allergy (fexofenadine hydrochloride) submitted by Chattem, Inc.
-
FDA approval · 2020-10-30FDA Approved: LORATADINE — Original Application (Tenshi Kaizen Pvt Ltd)
FDA approved an original generic application for loratadine (Tenshi Kaizen Pvt Ltd).
-
CLINICAL_TRIALS trial_result · 2020-10-29Clinical Trial Update: miRNA-155 Assay Before and After Immunotherapy and Probiotics [Phase 4]
Phase 4 clinical trial updating the miRNA-155 assay in the context of immunotherapy and probiotics for allergic rhinitis completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-10-20FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA Inc.'s supplemental application for Montelukast Sodium, marking approval of a generic montelukast product und…
-
FDA approval · 2020-10-20FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA Inc.'s supplemental application for Montelukast Sodium, authorizing a generic Montelukast product.
-
FDA approval · 2020-10-20FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved a supplemental application for Montelukast Sodium (ANDA 203432) from Ajanta Pharma USA Inc., granting approval of this generic …
-
CLINICAL_TRIALS trial_result · 2020-10-14Clinical Trial Update: Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis [Phase 4]
Phase 4 pediatric trial update for Sunovion growth study in children with mild asthma and allergic rhinitis has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2020-10-14Clinical Trial Update: Immunological Mechanisms of Oralair® in Patients With Seasonal Allergic Rhinitis [Phase 4]
Phase 4 trial update examining immunological mechanisms of Oralair in patients with seasonal allergic rhinitis.
-
CLINICAL_TRIALS trial_result · 2020-10-12Clinical Trial Update: Demonstration of Equivalence and Early Onset of a Novel Anti-allergic Nasal Spray Compared to Marketed Nasal Spray [Phase 3]
Phase 3 trial updating demonstration of equivalence and early onset for a novel anti-allergic nasal spray compared to a marketed spray; stud…
-
FDA approval · 2020-10-05FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Montelukast Sodium by Torrent Pharmaceuticals Limited (ANDA 201515).
-
CLINICAL_TRIALS trial_result · 2020-09-28Clinical Trial Update: The Safety and Efficacy of Intralymphatic Immunotherapy in Pollen Allergic Adolescents and Young Adults With Asthma [Phase 2, Phase 3]
Clinical trial updates safety and efficacy of intralymphatic immunotherapy in adolescents and young adults with pollen allergy–associated rh…
-
FDA approval · 2020-09-21FDA Approved: ALL DAY ALLERGY — Original Application (WALMART INC. (see also Equate))
FDA approved Walmart's All Day Allergy cetirizine hydrochloride as an original generic application (ANDA 213105), enabling a Walmart/Equate …
-
FDA approval · 2020-09-18FDA Approved: LORATADINE — Original Application (Tenshi Kaizen Pvt Ltd)
FDA approved Tenshi Kaizen Pvt Ltd's Loratadine as an original generic application. The product is indicated for allergic rhinitis and urtic…
-
FDA approval · 2020-09-11FDA Approved: CETIRIZINE HYDROCHLORIDE — Original Application (Aurohealth LLC)
FDA approved the original generic application for cetirizine hydrochloride to be marketed by Aurohealth LLC.
-
FDA approval · 2020-09-10FDA Approved: LORATADINE — Original Application (Advagen Pharma Limited)
FDA approved Advagen Pharma Limited's original ANDA for loratadine, a generic antihistamine indicated for allergic rhinitis and chronic idio…
-
FDA approval · 2020-09-04FDA Approved: MONTELUKAST — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application from Sandoz Inc for montelukast under the ANDA, confirming changes to the generic product's labeling…
-
FDA approval · 2020-09-04FDA Approved: MONTELUKAST SODIUM — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals' Montelukast Sodium as a generic version of montelukast for the prevention and maintenance treatment of …
-
CLINICAL_TRIALS trial_result · 2020-08-21Clinical Trial Update: Efficacy and Safety of Norketotifen in Adults With Allergic Rhinitis [Phase 2]
Phase 2 trial update on the efficacy and safety of norketotifen in adults with allergic rhinitis and rhinoconjunctivitis.
-
FDA approval · 2020-08-07FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application to add Claritin Chewable Grape and Bubblegum (loratadine) as a new chewable dosage form. This expand…
-
CLINICAL_TRIALS trial_result · 2020-07-16Clinical Trial Update: Safety and Efficacy of Sublingual Immunotherapy for Allergic Rhinitis Due to Artemisia Annua [Phase 3]
Phase 3 trial assessing safety and efficacy of sublingual immunotherapy for allergic rhinitis caused by Artemisia annua has completed.
-
FDA approval · 2020-07-15FDA Approved: BUDESONIDE — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for budesonide submitted by Padagis US LLC. The approval updates the labeling for budesonide under t…
-
FDA approval · 2020-07-14FDA Approved: BROMPHENIRAMINE, PSEUDOEPHEDRINE, DEXTROMETHORPHAN — Original Application (Ascend Laboratories, LLC)
FDA approves the original ANDA for a triple-ingredient cough/cold product containing brompheniramine, pseudoephedrine, and dextromethorphan …
-
CLINICAL_TRIALS trial_result · 2020-06-19Clinical Trial Update: Effects of Broccoli Sprout Extract on Allergy Rhinitis [Phase 2]
Phase 2 trial evaluating broccoli sprout extract for allergic rhinitis has completed with results posted.